|
ATCC
huvecs Huvecs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/huvecs/product/ATCC Average 99 stars, based on 1 article reviews
huvecs - by Bioz Stars,
2026-04
99/100 stars
|
Buy from Supplier |
|
PromoCell
huvecs Huvecs, supplied by PromoCell, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/huvecs/product/PromoCell Average 99 stars, based on 1 article reviews
huvecs - by Bioz Stars,
2026-04
99/100 stars
|
Buy from Supplier |
|
Angio-Proteomie
red fluorescent protein rfp human umbilical vein endothelial cells huvecs ![]() Red Fluorescent Protein Rfp Human Umbilical Vein Endothelial Cells Huvecs, supplied by Angio-Proteomie, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/red fluorescent protein rfp human umbilical vein endothelial cells huvecs/product/Angio-Proteomie Average 95 stars, based on 1 article reviews
red fluorescent protein rfp human umbilical vein endothelial cells huvecs - by Bioz Stars,
2026-04
95/100 stars
|
Buy from Supplier |
|
ATCC
primary umbilical vein endothelial cells; normal, human ![]() Primary Umbilical Vein Endothelial Cells; Normal, Human, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/primary umbilical vein endothelial cells; normal, human/product/ATCC Average 99 stars, based on 1 article reviews
primary umbilical vein endothelial cells; normal, human - by Bioz Stars,
2026-04
99/100 stars
|
Buy from Supplier |
|
ATCC
umbilical vein endothelial cell line ihuvec huvec tert 2 ![]() Umbilical Vein Endothelial Cell Line Ihuvec Huvec Tert 2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/umbilical vein endothelial cell line ihuvec huvec tert 2/product/ATCC Average 99 stars, based on 1 article reviews
umbilical vein endothelial cell line ihuvec huvec tert 2 - by Bioz Stars,
2026-04
99/100 stars
|
Buy from Supplier |
|
PromoCell
huvec cells ![]() Huvec Cells, supplied by PromoCell, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/huvec cells/product/PromoCell Average 99 stars, based on 1 article reviews
huvec cells - by Bioz Stars,
2026-04
99/100 stars
|
Buy from Supplier |
|
PromoCell
primary human umbilical vein endothelial cells huvec ![]() Primary Human Umbilical Vein Endothelial Cells Huvec, supplied by PromoCell, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/primary human umbilical vein endothelial cells huvec/product/PromoCell Average 99 stars, based on 1 article reviews
primary human umbilical vein endothelial cells huvec - by Bioz Stars,
2026-04
99/100 stars
|
Buy from Supplier |
|
ATCC
human umbilical vein endothelial cells huvec ![]() Human Umbilical Vein Endothelial Cells Huvec, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human umbilical vein endothelial cells huvec/product/ATCC Average 99 stars, based on 1 article reviews
human umbilical vein endothelial cells huvec - by Bioz Stars,
2026-04
99/100 stars
|
Buy from Supplier |
|
ATCC
human umbilical vein endothelial cells huvecs ![]() Human Umbilical Vein Endothelial Cells Huvecs, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/human umbilical vein endothelial cells huvecs/product/ATCC Average 99 stars, based on 1 article reviews
human umbilical vein endothelial cells huvecs - by Bioz Stars,
2026-04
99/100 stars
|
Buy from Supplier |
|
ATCC
crl 4053 tm ![]() Crl 4053 Tm, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/result/crl 4053 tm/product/ATCC Average 99 stars, based on 1 article reviews
crl 4053 tm - by Bioz Stars,
2026-04
99/100 stars
|
Buy from Supplier |
Journal: Materials Today Bio
Article Title: A microfluidic model of human dental pulp angiogenesis for preclinical drug and biomaterial testing
doi: 10.1016/j.mtbio.2026.102776
Figure Lengend Snippet: Sketch of a tooth injury where the highly vascularized dental pulp is exposed. Angiogenesis in the dental pulp is emulated on a three-channel microfluidic chip where dental pulp stem cells are seeded in fibrin hydrogel in the middle. HUVECs are seeded on the gel interface in the side channel, forming a monolayer that is sprouting into the gel. Here, the model is used for evaluating dentistry-related drugs and biomaterials.
Article Snippet:
Techniques:
Journal: Materials Today Bio
Article Title: A microfluidic model of human dental pulp angiogenesis for preclinical drug and biomaterial testing
doi: 10.1016/j.mtbio.2026.102776
Figure Lengend Snippet: A) Angiogenic sprouts from HUVECs stained with CD31 (red) growing in fibrin hydrogel containing different concentrations of dental pulp stem cells. Scale bars: 200 μm. B). Quantification of total vessel length (μm), vessel area fraction (%), branch point count and segment count for the different dental pulp stem cell concentrations. Each data point represents one chip analysed in four distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Article Snippet:
Techniques: Staining
Journal: Materials Today Bio
Article Title: A microfluidic model of human dental pulp angiogenesis for preclinical drug and biomaterial testing
doi: 10.1016/j.mtbio.2026.102776
Figure Lengend Snippet: A) Angiogenic sprouts from HUVECs stained with CD31 (red) growing in hydrogels with different fibrin concentrations. Scale bars: 100 μm. B). Quantification of total vessel length (μm), vessel area fraction (%), branch point count and segment count. Each data point represents one chip analysed for three distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Article Snippet:
Techniques: Staining
Journal: Materials Today Bio
Article Title: A microfluidic model of human dental pulp angiogenesis for preclinical drug and biomaterial testing
doi: 10.1016/j.mtbio.2026.102776
Figure Lengend Snippet: A) Flow generation driven by hydrostatic pressure from using pipette tips containing different volumes. B) Angiogenic sprouts of HUVECs stained with CD31 (red) growing during static (left), contra-directional (middle) or co-directional flow (right) conditions. Scale bars: 100 μm. C). Quantification of total vessel length (μm), vessel area fraction (%), branch point count and segment count for the different hydrostatic pressures. Each data point represents one chip analysed for four distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Article Snippet:
Techniques: Transferring, Staining
Journal: Materials Today Bio
Article Title: A microfluidic model of human dental pulp angiogenesis for preclinical drug and biomaterial testing
doi: 10.1016/j.mtbio.2026.102776
Figure Lengend Snippet: Maximum intensity projections of confocal z-stacks of angiogenic sprouts (A–D). A) Cross-section of angiogenic sprouts of HUVECs stained with CD31 (red), collagen IV (green) and dapi (blue). White arrows indicate collagen IV production by dental pulp stem cells. Scale bar: 50 μm. B) and C) angiogenic tip cells stained with CD31 (red), collagen IV (green) and dapi (blue). Scale bar: 40 μm. D) Cross-section of angiogenic sprouts with red fluorescent protein (RFP)-producing HUVECs (red) and dental pulp stem cells stained with vimentin (green). Scale bar: 7 μm. E) Angiogenic sprouts perfused with 1 μm fluorescent beads (green). Scale bar: 100 μm. F) Angiogenic sprouts perfused with 10 μm fluorescent beads (green). Scale bar: 100 μm. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Article Snippet:
Techniques: Staining
Journal: Materials Today Bio
Article Title: A microfluidic model of human dental pulp angiogenesis for preclinical drug and biomaterial testing
doi: 10.1016/j.mtbio.2026.102776
Figure Lengend Snippet: A) Maximum projections of confocal z-stacks showing growth of angiogenic sprouts from red fluorescent protein (RFP) producing HUVECs (red) monitored live over 3 days. Scale bars: 200 μm. B) Quantification of total vessel length (μm), mean segment length (μm), vessel area fraction (%), mean segment diameter (μm). Each data point represents one chip analysed for four distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Article Snippet:
Techniques:
Journal: Materials Today Bio
Article Title: A microfluidic model of human dental pulp angiogenesis for preclinical drug and biomaterial testing
doi: 10.1016/j.mtbio.2026.102776
Figure Lengend Snippet: A) Schematic sketch of treatment schedule for day 1. B) Maximum projections of confocal stacks of HUVECs (red, CD31) treated on day 1 and fixed on day 4. Scale bars: 200 μm. C) Quantification of cell death %, LDH release and fold increase in vessel area fraction and vessel length after treatment. Each data point represents one chip analysed for three distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Article Snippet:
Techniques:
Journal: Materials Today Bio
Article Title: A microfluidic model of human dental pulp angiogenesis for preclinical drug and biomaterial testing
doi: 10.1016/j.mtbio.2026.102776
Figure Lengend Snippet: A) Schematic sketch of treatment schedule for day 3. B) Maximum projections of confocal stacks of HUVECs (red, CD31) treated on day 3 and fixed on day 6. Scale bars: 200 μm. C) Quantification of cell death (in %), LDH release, fold increase in vessel area fraction and vessel length after treatment. Each data point represents one chip analysed for three distinct regions. Data presented as mean ± SD (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
Article Snippet:
Techniques:
Journal: STAR Protocols
Article Title: Protocol for large-scale, high-yield, high-purity extracellular vesicle purification from human plasma
doi: 10.1016/j.xpro.2026.104428
Figure Lengend Snippet: Fusion assay demonstrating the uptake of EVs from different fractions by cells EV populations were stained with DiI dye, then incubated with hTERT-HUVEC cells for 16 h. Cells were then fixed and DNA was stained with DAPI. Images taken at 20X and 100X magnification. Scale bar=10 μm
Article Snippet: hTERT-HUVEC (Human Telomerase Reverse Transcriptase (hTERT),
Techniques: Single Vesicle Fusion Assay, Staining, Incubation
Journal: iScience
Article Title: Cardiomyocyte-derived HSPB1 regulates TGF-β1 maturation and inhibits endothelial-to-mesenchymal transition in myocardial fibrosis
doi: 10.1016/j.isci.2026.115028
Figure Lengend Snippet: Regulatory role of HSPB1 in endothelial cell EndoMT (A) Western blot shows HSPB1 expression in HUVECs following lentiviral-mediated overexpression (LV-HSPB1) or knockdown (LV-HSPB1-RNAi); β-actin served as a loading control. (B) Quantification of HSPB1/β-actin ratio shows significant differences between groups. (C) Representative images of Transwell migration assays evaluating the effect of HSPB1 on TGF-β1–induced endothelial migration (scale bars, 100 μm). (D) Quantification of migrated cells per field. (E) Representative tube formation images showing the effect of HSPB1 modulation on TGF-β1–induced angiogenic activity (scale bars, 200 μm). (F–H) Quantitative analysis of tube formation parameters, including the number of branches (F), loops (G), and total tube length (H), measured using ImageJ software. Data are presented as mean ± SD ( n ≥ 6). Exact p values are indicated in the graphs. Statistical analyses were performed using one-way ANOVA followed by a Bonferroni post hoc test.
Article Snippet:
Techniques: Western Blot, Expressing, Over Expression, Knockdown, Control, Migration, Activity Assay, Software
Journal: iScience
Article Title: Cardiomyocyte-derived HSPB1 regulates TGF-β1 maturation and inhibits endothelial-to-mesenchymal transition in myocardial fibrosis
doi: 10.1016/j.isci.2026.115028
Figure Lengend Snippet: Effects of HSPB1 on signaling pathways and TGF-β secretion in HUVECs under hypoxic conditions (A and B) HUVECs were transfected with adenoviral vectors for HSPB1 overexpression (OE) or knockdown (KD) and cultured for 48 h before RNA extraction. Gene expression analysis was performed using RNA sequencing. Gene set enrichment analysis (GSEA) assessed the regulatory roles of HSPB1 in processes such as heart development, angiogenesis, and cell proliferation (A). Further analysis using Hallmark gene sets explored HSPB1 signaling pathway activation (B). (C–G) Following transfection, HUVECs were cultured for 24 h and subjected to hypoxic conditions (3% O 2 ) for 48 h. Western blot analysis of the indicated proteins was performed. (D) pSmad2/3/Smad2/3 ratio, (E) quantification of CD31 protein expression, (F) quantification of E-cadherin expression, (G) quantification of α-SMA expression, and (H) quantification of N-cadherin expression were measured relative to β-actin. (I) TGF-β levels were measured by ELISA in cell supernatants. Data are presented as mean ± SD ( n ≥ 6). Exact p values are indicated in the graphs. Statistical analyses were performed using one-way ANOVA followed by a Bonferroni post hoc test.
Article Snippet:
Techniques: Protein-Protein interactions, Transfection, Over Expression, Knockdown, Cell Culture, RNA Extraction, Gene Expression, RNA Sequencing, Activation Assay, Western Blot, Expressing, Enzyme-linked Immunosorbent Assay